FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

716016006: Daratumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3304443015 Daratumumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3304444014 Daratumumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daratumumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Daratumumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing daratumumab in parenteral dose form (medicinal product form) Has active ingredient True Daratumumab Inferred relationship Existential restriction modifier 1
Product containing daratumumab (medicinal product) Has active ingredient True Daratumumab Inferred relationship Existential restriction modifier 1
Daratumumab Has active ingredient True Daratumumab Inferred relationship Existential restriction modifier 1
Product containing only daratumumab in parenteral dose form (medicinal product form) Has active ingredient True Daratumumab Inferred relationship Existential restriction modifier 1
Product containing precisely daratumumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Daratumumab Inferred relationship Existential restriction modifier 1
Product containing precisely daratumumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Daratumumab Inferred relationship Existential restriction modifier 1
Daratumumab 1.8g/15ml solution for injection vials Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 1800mg/15ml solution for injection vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Daratumumab 1.8g/15ml solution for injection vials 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 1800mg/15ml solution for injection vials (Janssen-Cilag Ltd) Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Daratumumab 100mg/5ml solution for infusion vials Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Daratumumab 400mg/20ml solution for infusion vials Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Daratumumab 400mg/20ml solution for infusion vials 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Daratumumab 100mg/5ml solution for infusion vials 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Daratumumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start